Kirkov Kirko's Form 4 filing
Elite Pharmaceuticals Inc (ELTP) · filed Jul 25, 2025
- Accession no.
- 0001946043-25-000002
- Filed
- Jul 25, 2025
- Trade date
- Jul 10, 2025
- Filing delay
- 15 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $9.66K. It was filed 15 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Kirkov KirkoCIK 0001946043 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 10, 2025 | Common Stock | PPurchaseAcquired | +16,366 | $0.59 | +$9,655.94 | 16,366 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.